267 related articles for article (PubMed ID: 28159780)
21. Short-term change in kidney function and risk of end-stage renal disease.
Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
[TBL] [Abstract][Full Text] [Related]
22. Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support.
Lok SI; Winkens B; Goldschmeding R; van Geffen AJ; Nous FM; van Kuik J; van der Weide P; Klöpping C; Kirkels JH; Lahpor JR; Doevendans PA; de Jonge N; de Weger RA
Eur J Heart Fail; 2012 Nov; 14(11):1249-56. PubMed ID: 22843564
[TBL] [Abstract][Full Text] [Related]
23. Circulating GDF-15 in relation to the progression and prognosis of chronic kidney disease: A systematic review and dose-response meta-analysis.
Zhou Z; Liu H; Ju H; Chen H; Jin H; Sun M
Eur J Intern Med; 2023 Apr; 110():77-85. PubMed ID: 36740468
[TBL] [Abstract][Full Text] [Related]
24. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
25. Circulating endoglin concentration is not elevated in chronic kidney disease.
Charytan DM; Helfand AM; MacDonald BA; Cinelli A; Kalluri R; Zeisberg EM
PLoS One; 2011; 6(8):e23718. PubMed ID: 21886815
[TBL] [Abstract][Full Text] [Related]
26. Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression.
Bowe B; Xie Y; Xian H; Balasubramanian S; Al-Aly Z
Kidney Int; 2016 Apr; 89(4):886-96. PubMed ID: 26924057
[TBL] [Abstract][Full Text] [Related]
27. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease.
Breit SN; Carrero JJ; Tsai VW; Yagoutifam N; Luo W; Kuffner T; Bauskin AR; Wu L; Jiang L; Barany P; Heimburger O; Murikami MA; Apple FS; Marquis CP; Macia L; Lin S; Sainsbury A; Herzog H; Law M; Stenvinkel P; Brown DA
Nephrol Dial Transplant; 2012 Jan; 27(1):70-5. PubMed ID: 21940482
[TBL] [Abstract][Full Text] [Related]
28. Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
Poesen R; Ramezani A; Claes K; Augustijns P; Kuypers D; Barrows IR; Muralidharan J; Evenepoel P; Meijers B; Raj DS
Clin J Am Soc Nephrol; 2015 Sep; 10(9):1525-33. PubMed ID: 26153127
[TBL] [Abstract][Full Text] [Related]
29. Thyroid hormones associate with risk of incident chronic kidney disease and rapid decline in renal function: a prospective investigation.
Huang X; Ding L; Peng K; Lin L; Wang T; Zhao Z; Xu Y; Lu J; Chen Y; Wang W; Bi Y; Ning G; Xu M
J Transl Med; 2016 Dec; 14(1):336. PubMed ID: 27914474
[TBL] [Abstract][Full Text] [Related]
30. Interankle systolic blood pressure difference and renal outcomes in patients with chronic kidney disease.
Chen SC; Tsai YC; Huang JC; Lee SC; Chang JM; Hwang SJ; Chen HC
Nephrology (Carlton); 2016 May; 21(5):379-86. PubMed ID: 26370877
[TBL] [Abstract][Full Text] [Related]
31. Urinary growth differentiation factor 15 predicts renal function decline in diabetic kidney disease.
Oshita T; Watanabe S; Toyohara T; Kujirai R; Kikuchi K; Suzuki T; Suzuki C; Matsumoto Y; Wada J; Tomioka Y; Tanaka T; Abe T
Sci Rep; 2023 Aug; 13(1):12508. PubMed ID: 37532799
[TBL] [Abstract][Full Text] [Related]
32. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
33. Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study.
Baek SD; Baek CH; Kim JS; Kim SM; Kim JH; Kim SB
Scand J Urol Nephrol; 2012 Jun; 46(3):232-8. PubMed ID: 22545920
[TBL] [Abstract][Full Text] [Related]
34. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
[TBL] [Abstract][Full Text] [Related]
35. Magnesium modifies the association between serum phosphate and the risk of progression to end-stage kidney disease in patients with non-diabetic chronic kidney disease.
Sakaguchi Y; Iwatani H; Hamano T; Tomida K; Kawabata H; Kusunoki Y; Shimomura A; Matsui I; Hayashi T; Tsubakihara Y; Isaka Y; Rakugi H
Kidney Int; 2015 Oct; 88(4):833-42. PubMed ID: 26061542
[TBL] [Abstract][Full Text] [Related]
36. Long-term fate of renal function after open surgery for juxtarenal and pararenal aortic aneurysm.
Sugimoto M; Takahashi N; Niimi K; Kodama A; Banno H; Komori K
J Vasc Surg; 2018 Apr; 67(4):1042-1050. PubMed ID: 28964618
[TBL] [Abstract][Full Text] [Related]
37. Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study.
Dobre M; Yang W; Pan Q; Appel L; Bellovich K; Chen J; Feldman H; Fischer MJ; Ham LL; Hostetter T; Jaar BG; Kallem RR; Rosas SE; Scialla JJ; Wolf M; Rahman M;
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25896890
[TBL] [Abstract][Full Text] [Related]
38. Validation of the kidney failure risk equation in European CKD patients.
Peeters MJ; van Zuilen AD; van den Brand JA; Bots ML; Blankestijn PJ; Wetzels JF;
Nephrol Dial Transplant; 2013 Jul; 28(7):1773-9. PubMed ID: 23645476
[TBL] [Abstract][Full Text] [Related]
39. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
[TBL] [Abstract][Full Text] [Related]
40. Impact of Uric Acid Levels on Kidney Disease Progression.
Rincon-Choles H; Jolly SE; Arrigain S; Konig V; Schold JD; Nakhoul G; Navaneethan SD; Nally JV; Rothberg MB
Am J Nephrol; 2017; 46(4):315-322. PubMed ID: 29032376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
